🇺🇸 FDA

Company profile · Sponsor

Dong

Dong Wang

C759124 · NMPA pharma CN
Pipeline
8
Drugs
0
Patents
0

Quick answer

Dong (C759124) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 8 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker C759124
Exchange NMPA
Company type pharma
Headquarters CN

Pipeline (8)

Search pipeline →

  1. Telmisartan/Amlodipine

    Dong

    Hypertension With Hyperlipidemia

    phase 3 small molecule completed

    1 trial

  2. evogliptin

    Dong

    Type 2 Diabetes Mellitus

    phase 3 small molecule completed

    1 trial

  3. DA-4001C

    Dong

    Androgenetic Alopecia

    phase 2 small molecule completed

    1 trial

  4. Aricept 5mg Tablet

    Dong

    Healthy

    phase 1 small molecule active

    1 trial

  5. DA-5210 10/500mg

    Dong

    Healthy

    phase 1 small molecule completed

    1 trial

  6. De-escalation strategy

    Dong

    Acute Myocardial Infarction

    approved small molecule active

    1 trial

  7. Risedronate Sodium 35 MG [Actonel]

    Dong

    Postmenopausal Osteoporosis

    approved small molecule completed

    1 trial

  8. rivastigmine patch

    Dong

    Alzheimer's Disease

    small molecule completed

    1 trial

Frequently asked questions

What is Dong?

Dong (C759124) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 8 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Dong sponsor?

We track 8 ClinicalTrials.gov-linked programs for Dong, including Telmisartan/Amlodipine and 7 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Dong company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.